Jiaxuan Qiu

Jiaxuan Qiu

Auto-generated profile, based on publicly available information

Jiaxuan Qiu

Jiangxi Provincial Key Laboratory of Oral Diseases, Department of Stomatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2025 in Medicine
Verified
Journal Article
Open access
ZXZichen Xu
Zichen Xu
YXYuqi Xin
Yuqi Xin
XZXinjian Zhang
Xinjian Zhang
JLJianwei Liu
Jianwei Liu
YLYang Liu
Yang Liu
JQJiaxuan Qiu
Jiaxuan Qiu
Plumbagin is a biologically active naphthoquinone compound. Research related to plumbagin has gained popularity, evidenced by a gradual increase in publications. However, a bibliometric study in this field has yet to be conducted. Consequently, this study aims to evaluate the global scientific output of plumbagin research through bibliometric analysis, explore the status of research in this field over the past 15 years, and predict its future research hotspots. Visual analysis software, including CiteSpace, VOSviewer, and the R package ‘bibliometrix’, was employed to analyze all literature pertaining to plumbagin published between 2009 and 2024. Bibliometric records were sourced from the Web of Science Core Collection. This study analyzed a total of 2061 publications. China was found to have the largest number of publications, while the Council of Scientific & Industrial Research recorded the highest publication count in this field. Thomas and David D were identified as the authors with the most publications. The journal with the highest number of citations was J Biol Chem, and Padhye S was noted as the author with the highest citation count. In recent years, cancer treatment has emerged as the most closely related research topic concerning plumbagin, and keyword cluster analysis highlighted ‘sarcoplasmic reticulum’ as a prominent research keyword. Through quantitative and visual analysis of plumbagin, this study reveals that plumbagin research remains a valuable field. Anticancer treatment of plumbagin is identified as a future research direction.

26 December 2025 in Medicine
Verified
Journal Article
Open access
XZXinjian Zhang
Xinjian Zhang
YXYuqi Xin
Yuqi Xin
FHFei He
Fei He
YLYang Liu
Yang Liu
佳邵佳慧 邵
佳慧 邵
JQJiaxuan Qiu
Jiaxuan Qiu
The host’s immune inflammatory response plays a crucial role in the pathogenesis of temporomandibular disorders (TMD), involving numerous innate immune effector cells to initiate the initial inflammatory response. However, the regulation of immune function and the composition of immune cells in relation to the occurrence and development of TMD remain incompletely elucidated. The genetic causality of immune cells on TMD was studied using Mendelian randomization in a two-sample study. With the help of publicly available genetic data, we examined the causal associations between 731 immune cell signatures and TMD risk. For the causal effect analysis, an inverse variance-weighted random effect model was applied. Several sensitivity analyses were conducted by using Cochran’s Q tests, funnel plots, leave-one-out analyses, and Mendelian randomization-Egger intercept tests. Twenty-nine immune cell traits might be causally related to TMD. Among these traits, 11 exhibited potential positive causal effects, while the remaining 18 displayed negative causal effects on TMD. Moreover, no substantial evidence of heterogeneity or pleiotropy was observed. We have demonstrated a close genetic connection between immune cells and TMD, unraveling the underlying mechanisms linking immune dysregulation and TMD will contribute to our understanding of the pathophysiology of this debilitating condition.

5 June 2026 in Medicine
Verified
Journal Article
Open access
FYFei Yu
Fei Yu
XWXiwen Wan
Xiwen Wan
JQJiaxuan Qiu
Jiaxuan Qiu
Osteoporosis is a highly heritable metabolic bone disorder characterized by low bone mass and increased fracture risk. However, the causal genes underlying disease susceptibility remain incompletely understood. In this study, we employed a summary-data-based Mendelian randomization (SMR) framework to identify genes with potential causal effects on osteoporosis by integrating genome-wide association study summary statistics from the FinnGen consortium with multilayer molecular quantitative trait loci (xQTL) data, including expression, splicing, methylation, and protein QTLs across multiple tissues (106 xQTL datasets in total). The heterogeneity in dependent instruments (HEIDI) test was applied to distinguish pleiotropic associations from linkage disequilibrium-driven effects. Functional characterization was further conducted using Gene Ontology and KEGG pathway enrichment analyses, protein–protein interaction network construction, drug–gene enrichment analysis, and molecular docking. Using this integrative approach, we identified 15 high-confidence genes – CEP112, CKB, GID4, MEOX1, MEPE, PPP6R3, RGS9, RSPO3, SERPINA1, SFRP4, SOST, SPP1, SREBF1, TOM1L2, and ZBTB48 – showing evidence of causal associations with osteoporosis after stringent multiple-testing correction and HEIDI filtering. These genes included established regulators of bone metabolism as well as novel candidates involved in metabolic regulation and signal transduction. Enrichment analyses highlighted pathways related to Wnt and bone morphogenetic protein signaling, extracellular matrix organization, and metabolic processes, while network analysis revealed substantial functional connectivity among the prioritized genes. In addition, drug–gene enrichment analysis prioritized β-carotene, apocarotenal, and bezafibrate as potential therapeutic candidates, with molecular docking supporting stable interactions with key protein targets. Overall, this study provides robust genetic evidence for causal molecular regulators of osteoporosis and highlights potential therapeutic targets, offering a clinically relevant resource for future functional validation and translational research.